about
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancerNetwork-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer RiskPALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSIdentification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.Assessing the genetic architecture of epithelial ovarian cancer histological subtypes.No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancerGenome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancerScreening of Finnish RAD51C founder mutations in prostate and colorectal cancer patients.Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer familiesIdentification of six new susceptibility loci for invasive epithelial ovarian cancer.Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) RiskCis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancerVariants on the promoter region of PTEN affect breast cancer progression and patient survival.RAD51B in Familial Breast CancerShared genetics underlying epidemiological association between endometriosis and ovarian cancer.Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer.Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer.Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) RiskCommon Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC).Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancerEvaluating the ovarian cancer gonadotropin hypothesis: a candidate gene studyBRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian CancersIdentification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families.Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration.Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study.Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization studyFANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population.HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk.RAD51C is a susceptibility gene for ovarian cancerScreening of HELQ in breast and ovarian cancer families
P50
Q24633316-593A8A4A-47FC-450F-9144-382A71DE0EB7Q26799669-B540CCE4-15F6-446A-B233-F4C37F49409CQ28584533-195267E7-5E1A-4829-AF79-3C9F728866FDQ30252854-F68BFB96-1E60-422E-AFB5-57491A5E77AAQ30276986-52C53D95-23DB-4351-8A98-F0E5683A5804Q30374367-E0B8DF37-B336-47F6-833B-2B99D6C146E9Q33663091-DEB8400C-EDBB-4CF5-A8B0-DA84C931128FQ33778612-FD835898-A1F4-4F21-A328-CD5CD32F6727Q34342248-23A7C720-E238-421E-9BAC-8CC90E1EA3A7Q34408752-F0CB10D9-21DE-4711-87B4-81005DB5B872Q34486808-6E7040CE-A340-4BC0-BAE7-5EAF084282FCQ34996647-B5C9C4AC-7C5F-4165-AEFE-69F09D179B42Q35502165-129334B6-9142-468D-8686-56343BBA08EFQ35541663-642A24DB-B700-424B-A7B3-E09EB79A764AQ35668946-7A0A4A22-4BAD-43E4-B3D8-A2F397719EE9Q35782435-1FEDBD81-199D-460B-945D-F7D0AB941625Q35889659-17B80BAF-69AC-43A6-8F6B-9AA546A3BD22Q36009422-EF5F9626-5A54-4309-92E0-3B4C9368BFDEQ36089391-BAB11431-7192-4D31-B769-61C6FEFA7134Q36255665-F777E8CE-5567-49CD-886D-F28CA57BBE35Q36385656-1B16E17E-D8C4-4913-8BF7-90E0DC0B506EQ36487146-E42FEE26-8B62-47BF-812E-5C12BCC748A3Q36490507-625E408B-79CB-473C-8FAA-B1575419ACA5Q36897003-5B64DB68-5477-43FF-8AE7-2CC4EFBA6AB5Q36956156-343AE7D9-87DB-46F7-96E6-F3E4FA5801ABQ36966218-BE9EFB6E-86DD-4B1A-ADB3-3291ECECF778Q37002955-B29D1511-F205-45E3-A90D-94A382C221B4Q37006170-892D0FE9-C974-4CAC-A1D2-130469085BCFQ37131918-6D99FFC1-8D80-4794-B418-8F43B49F8417Q37624504-3422E763-3E5A-4868-9C40-D96839EEF294Q37684409-62D94168-D9FC-408F-8BB3-F3CCB1A8E270Q37684424-9D59A91D-4EC5-470A-BFE4-AAD521EE7794Q38406780-ABE6F493-CA73-448E-8BE9-FAE21E36E717Q39423088-D363038B-63A6-49D7-BB66-BADF167D6FD9Q42683589-3A986078-2146-491B-A1E6-189B4C5B11EFQ44708071-505169E4-15C4-4A8A-803C-E866AF45E69BQ57306209-04928FD8-041E-4F4B-92B4-BF64FFE4D616Q57754538-4D3AAB5F-868E-4D17-8852-9A06AD84242D
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Liisa Pelttari
@ast
Liisa Pelttari
@en
Liisa Pelttari
@es
Liisa Pelttari
@nl
Liisa Pelttari
@sl
type
label
Liisa Pelttari
@ast
Liisa Pelttari
@en
Liisa Pelttari
@es
Liisa Pelttari
@nl
Liisa Pelttari
@sl
altLabel
Liisa M Pelttari
@en
prefLabel
Liisa Pelttari
@ast
Liisa Pelttari
@en
Liisa Pelttari
@es
Liisa Pelttari
@nl
Liisa Pelttari
@sl
P106
P21
P31
P496
0000-0001-8091-9751